How different shapes of proteins affect cell signaling
Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin Conformations
This study is looking at how certain proteins in our bodies, called GPCRs, work with other proteins known as beta-arrestins, which could help us find better ways to use medications and improve treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10906362 on NIH RePORTER |
What this research studies
This research investigates how G protein-coupled receptors (GPCRs), which are crucial for many bodily functions and are targeted by a significant portion of medications, interact with proteins called beta-arrestins. The study focuses on understanding the different conformations of beta-arrestins and how they regulate the signaling pathways initiated by GPCRs. By examining these interactions, the research aims to uncover new mechanisms that control cellular responses and potentially lead to improved drug targeting strategies. Patients may benefit from insights gained about how to enhance or modify drug effects based on these signaling pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve GPCR signaling, such as cardiovascular diseases, neurological disorders, or metabolic syndromes.
Not a fit: Patients with conditions unrelated to GPCR signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments by improving how drugs target GPCRs, potentially enhancing patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding GPCR signaling, indicating that this approach has the potential for significant advancements in the field.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Thomsen, Alex Rojas Bie — New York University
- Study coordinator: Thomsen, Alex Rojas Bie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.